New avenues to treatment of liver cirrhosis by XueShuai Wan & HaiTao Zhao
SCIENCE CHINA 
Life Sciences 
© The Author(s) 2014. This article is published with open access at link.springer.com life.scichina.com   link.springer.com 
                  
*Corresponding author (email: zhaoht@pumch.cn) 
• NEWS AND VIEWS • October 2014  Vol.57  No.10: 1049–1050 
 doi: 10.1007/s11427-014-4751-x 
New avenues to treatment of liver cirrhosis 
WAN XueShuai & ZHAO HaiTao* 
Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical 
College, Beijing 100730, China 
Received August 20, 2014; accepted September 2, 2014; published online September 16, 2014 
 




Liver cirrhosis is the pathologic end stage of multiple liver 
diseases. The major complications of liver cirrhosis, such as 
hepatic encephalopathy, spontaneous bacterial peritonitis 
and esophageal variceal bleeding are characterized by re-
markable changes of the gut microbiota, which indicates 
that enteric dysbiosis might play an important role in the 
progression of liver cirrhosis [1,2]. The human gastrointes-
tinal tract hosts 5001500 different bacteria species con-
taining nearly 1014 bacteria, which is 10-fold larger than that 
of human cells [3,4]. However, their phylogenetic and func-
tional composition changes in liver cirrhosis are still largely 
unknown. 
Using quantitative metagenomics analysis developed by 
metagenomics of the Human Intestinal Tract [6], Prof. Li 
and her team built the world’s first reference gene set of gut 
microbiota in liver cirrhosis by studying stool samples from 
98 patients and 83 healthy control individuals. Of the 2.69 
million genes in this liver cirrhosis catalogue, 36.1% of 
which are novel, indicating that more unknown genes could 
be identified by inclusion of more subjects. They also dis-
covered the compositional changes in gut microbiota related 
to liver cirrhosis. At the phylum level, Bacteroidetes was 
significantly decreased in the liver cirrhosis group, while 
Proteobacteria and Fusobacteria were increased. At the ge-
nus level, patients with liver cirrhosis had fewer Bac-
teroides, but higher levels to Veillonella, Streptococcus, 
Clostridium and Prevotella. To investigate the microbial 
genes associated with liver cirrhosis, Prof. Li’s group iden-
tified a total of 75245 genes and further grouped them into 
66 metagenomic species. Interestingly, Faecalibacterium 
prausnitzii and Coprococcus comes were enriched in 
healthy controls and they had the ability to fight inflamma-
tion and produce butyrate, respectively. These findings will 
facilitate therapeutic attempts to correct the major dysbioses 
in gut microbiota and therefore open new avenues to treat-
ment of liver cirrhosis.  
When the origin of species enriched in patient groups 
were explored using HOMD and GOLD databases [6], sur-
prisingly, 54% of them were found to be of buccal origin, 
indicating that a major change of gut microbiota in the pa-
tients with liver cirrhosis might be the consequence of a 
massive invasion of the gut by oral bacterial species.  
The functional role of the gut microbiota in liver cirrho-
sis was elucidated by identifying their orthologues [6]. At 
the module or pathway level, the liver-cirrhosis-associated 
markers included various pathophysiologic processes in 
cirrhosis complications, especially hepatic encephalopathy. 
To translate their research findings to clinical practice, they 
selected 15 optimal gene markers and proposed a patient 
discrimination index (PDI), which could discriminate pa-
tients with liver cirrhosis from healthy individuals, with a 
high specificity.  
The study [6] provided us a more profound understand-
ing of the gut microbiota in liver cirrhosis. However, as we 
know, hepatitis B virus infection is one of the leading caus-
es to liver cirrhosis in China and other Asian countries, 
while alcohol-related cirrhosis is a major cause of morbidity 
and mortality in Western countries. In Prof. Li’s previous 
study, they found the fecal microbial communities between 
HBV-related and alcohol-related cirrhosis was similar and 
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concluded that the composition changes between different 
fecal microbiota were mostly due to cirrhosis [5]. Recently, 
Bajaj et al. found a different pattern of dysbiosis in alcohol-
ic cirrhosis with higher Enterobacteriaceae and endotoxe-
mia compared to non-alcoholic patients [1]. Therefore, it 
seemed to be necessary to compare the gut microbiota be-
tween HBV-related and alcohol-related cirrhosis with rela-
tively larger sample size in future studies.  
Taken together, this is an important study demonstrating 
the alterations of the human gut microbiome in liver cirrho-
sis. Understanding the exact compositional changes will 
greatly enhance our ability to modulate the gut microbiota 
and treat liver cirrhosis. 
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